Sphera Funds Management Ltd. Beam Therapeutics Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$84.37 - $133.6 $2.4 Million - $3.8 Million	-28,425 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$64.12 - $128.71 $1.82 Million - $3.66 Million	28,425 New	28,425 $3.66 Million
Q2 2020 Aug 13, 2020	SELL	$15.26 - $28.66 $4.04 Million - $7.59 Million	-264,681 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$13.31 - $29.2 $3.52 Million - $7.73 Million	264,681 New	264,681 $4.76 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.